Medcura, Inc.
PrivateLast Round
Series B
Jul 20, 2025
Total Funding Raised
$43.3M
Momentum Score
25 /100
Company Overview
Medcura, Inc. is a medical device company that develops and commercializes a portfolio of hemostatic products designed to control bleeding in surgical, medical, and consumer applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Defense Tech
Business Model
B2B2C
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medcura, Inc. Comps
Public and private peers based on sector, stage, and business model.
Medcura, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 20, 2025 | ||||
| Convertible Debt | Apr 3, 2024 | ||||
| Grant | Sep 8, 2022 | ||||
| Series A | Aug 12, 2021 | ||||
| Private Placement | Jul 13, 2017 |
Medcura, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Grant |
| UM Ventures | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2025
$13M round closed
- Jul 8, 2025
Monthly visitors increased 48% MoM, reaching 3.4K.
Medcura, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medcura, Inc.'s valuation, stock price, and market status.
